Kouki Harasaki

Bioluminescence Ventures is a leading biotechnology venture capital firm that invests in the future of medicine.

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Raised $189,500,000.00 from MQB Partners, Lightstone Ventures, Bioluminescence Ventures, Gates Frontier Fund, LifeRock Ventures, Google Ventures, Double Point Ventures, Agent Capital, Foresite Capital and Gates Frontier Fund.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Raised $58,000,000.00 from Camford Capital, Piedmont Capital, Green D Ventures, Intuitive Ventures, Alumni Ventures, Cancer Research Institute, Castor Ventures, Pitango VC, Khosla Ventures and DHVC.

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

Raised $205,000,000.00 from Delos Capital, Bioluminescence Ventures, Kite Pharma, SymBiosis LLC, Catalio Capital Management, Solasta Ventures, Qatar Investment Authority, Mirae Asset, 5AM Ventures and Alexandria Venture Investments.

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

Raised $109,000,000.00 from Bioluminescence Ventures.

M12 is the venture capital arm of Microsoft that invests in early-stage companies.

1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development.

Raised $26,650,000.00 from Accenture Ventures.

Artificial is a software company that develops a lab automation platform.

Raised $21,500,000.00 from M12 - Microsoft's Venture Fund, Playground Global and AME Cloud Ventures.